文献
J-GLOBAL ID:202102210599508435
整理番号:21A0015268
新規CD160-ROR1アッセイを用いた慢性リンパ性白血病における最小残存疾患の高感度かつ正確な評価【JST・京大機械翻訳】
Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay
著者 (5件):
Farren Timothy W.
(1Department of Haemato-Oncology and Immunophenotyping (SIHMDS), Barts Health NHS Trust, London, United Kingdom)
,
Farren Timothy W.
(2Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom)
,
Sadanand Kaushik S.
(2Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom)
,
Agrawal Samir G.
(1Department of Haemato-Oncology and Immunophenotyping (SIHMDS), Barts Health NHS Trust, London, United Kingdom)
,
Agrawal Samir G.
(2Immunobiology, Blizard Institute, Queen Mary University of London, London, United Kingdom)
資料名:
Frontiers in Oncology (Web)
(Frontiers in Oncology (Web))
巻:
10
ページ:
597730
発行年:
2020年
JST資料番号:
U7089A
ISSN:
2234-943X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)